What ONYX PHARMACEUTICALS INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Cagnoni Pablo J | EVP, Global R&D and Tech Ops | Oct 01 | Disposition to Issuer · D | −16,257 | $125.00 | −$2.03M | 0 |
| Torley Helen | EVP, Chief Commercial Officer | Oct 01 | Disposition to Issuer · D | −28,575 | $125.00 | −$3.57M | 0 |
| Torley Helen | EVP, Chief Commercial Officer | Oct 01 | Tender Offer · U | −7,336 | $125.00 | −$917K | 28,575 |
| Wiggans Thomas G | Director | Oct 01 | Disposition to Issuer · D | −2,100 | $125.00 | −$263K | 0 |
| Wiggans Thomas G | Director | Oct 01 | Tender Offer · U | −6,015 | $125.00 | −$752K | 2,100 |
| Fust Matthew K | EVP & Chief Financial Officer | Oct 01 | Disposition to Issuer · D | −31,150 | $125.00 | −$3.89M | 0 |
| Fust Matthew K | EVP & Chief Financial Officer | Oct 01 | Tender Offer · U | −9,153 | $125.00 | −$1.14M | 31,150 |
| Foster-Cheek Kaye I | SVP, Global Human Resources | Oct 01 | Disposition to Issuer · D | −21,400 | $125.00 | −$2.68M | 0 |
| Foster-Cheek Kaye I | SVP, Global Human Resources | Oct 01 | Tender Offer · U | −5,666 | $125.00 | −$708K | 21,400 |
| Goddard Paul | Director | Oct 01 | Disposition to Issuer · D | −2,100 | $125.00 | −$263K | 0 |
| Goddard Paul | Director | Oct 01 | Tender Offer · U | −12,790 | $125.00 | −$1.6M | 2,100 |
| Lasowski Juergen | EVP, Corp. Dev & Strategy | Oct 01 | Disposition to Issuer · D | −30,250 | $125.00 | −$3.78M | 0 |
| Lasowski Juergen | EVP, Corp. Dev & Strategy | Oct 01 | Tender Offer · U | −1,833 | $125.00 | −$229K | 30,250 |
| Lyle Corinne H | Director | Oct 01 | Disposition to Issuer · D | −2,100 | $125.00 | −$263K | 0 |
| Lundberg Magnus | Director | Oct 01 | Disposition to Issuer · D | −2,100 | $125.00 | −$263K | 0 |
| Lundberg Magnus | Director | Oct 01 | Tender Offer · U | −12,116 | $125.00 | −$1.51M | 2,100 |
| Grillo Lopez Antonio J | Director | Oct 01 | Disposition to Issuer · D | −2,100 | $125.00 | −$263K | 0 |
| Coles N Anthony | Chairman & CEO | Oct 01 | Disposition to Issuer · D | −105,566 | $125.00 | −$13.2M | 0 |
| Coles N Anthony | Chairman & CEO | Oct 01 | Tender Offer · U | −25,632 | $125.00 | −$3.2M | 105,566 |
| Ringo William R | Director | Oct 01 | Disposition to Issuer · D | −2,100 | $125.00 | −$263K | 0 |
Loading...
